Inverna Therapeutics
PrivateLast Round
Grant
Oct 9, 2025
Company Overview
Inverna Therapeutics operates in Healthcare & Life Sciences and is based in Odense. Its latest recorded funding round was a Grant round in October 2025.
Inverna Therapeutics is a biotechnology company that is a developer of a next-generation ribonucleic acid splicing modulation platform intended to transform patient outcomes in severe genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inverna Therapeutics Comparables
Compare Inverna Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Harness Therapeutics | 79% | |
| Vico | 76% | |
| Skyhawk Therapeutics | 73% |
For institutional investors. Book with your work email.
Inverna Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 9, 2025 | ||||
| Seed | Jan 7, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inverna Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Southern Denmark | Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 509% MoM, from 157 to 956.
- Apr 17, 2026
Monthly visitors increased 139% MoM.
For institutional investors. Book with your work email.
Inverna Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inverna Therapeutics's valuation, stock price, and market status.
Is Inverna Therapeutics a public or private company?
Inverna Therapeutics is a private company.
What is the current stock price of Inverna Therapeutics?
Inverna Therapeutics is a private company, so its shares have no public market price. Caplight tracks Inverna Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inverna Therapeutics worth (valuation)?
Valuation information for Inverna Therapeutics is not publicly available.
Can I buy Inverna Therapeutics stock?
Inverna Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inverna Therapeutics's last funding round?
Inverna Therapeutics's most recent funding round was Grant on October 9, 2025.
Who are the main investors in Inverna Therapeutics?
Key investors in Inverna Therapeutics include University of Southern Denmark, The Michael J. Fox Foundation for Parkinson's Research.
Will Inverna Therapeutics IPO soon?
No public IPO plans have been announced for Inverna Therapeutics.
How can I track Inverna Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Inverna Therapeutics's shares on secondary markets.